Nutshell Therapeutics
PrivateLast Round
Series A
Extension
Mar 14, 2022
Total Funding Raised
$60M
Company Overview
Nutshell Therapeutics is a biotechnology company that develops small molecule drugs for challenging targets using its proprietary AI-driven allosteric drug discovery platform, AlloStar.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Medical AI
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nutshell Therapeutics Comparables
Compare Nutshell Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Atavistik Bio | 85% | |
| HotSpot Therapeutics | 82% | |
| UCDOM BioTech (Shanghai) Co., Ltd. | 79% | |
Nutshell Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Mar 14, 2022 | ||||
| Series A | Jan 13, 2022 | ||||
| VC Round | Sep 6, 2015 |
Key People
Founding team and executive leadership
Nutshell Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Baidu Ventures | Series A |
| Northern Light Venture Capital | Series A |
| MPC | Series A |
| Source Code Capital | Series A |
| Genesis Capital | Series A Extension |
| Kunlun Capital | Series A |
| Straylight Capital | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 14, 2022
$40M round led by Genesis Capital.
Nutshell Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Nutshell Therapeutics's valuation, stock price, and market status.